<VariationArchive VariationID="10460" VariationName="Multiple alleles" VariationType="Haplotype" Accession="VCV000010460" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-01-26" DateCreated="2019-02-04" MostRecentSubmission="2019-02-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <Haplotype VariationID="10460" NumberOfChromosomes="1">
      <SimpleAllele AlleleID="1867369" VariationID="1810355">
        <GeneList>
          <Gene Symbol="COL4A5" FullName="collagen type IV alpha 5 chain" GeneID="1287" HGNC_ID="HGNC:2207" Source="submitted" RelationshipType="asserted, but not computed">
            <Location>
              <CytogeneticLocation>Xq22.3</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="108439838" stop="108697545" display_start="108439838" display_stop="108697545" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="107683073" stop="107940774" display_start="107683073" display_stop="107940774" Strand="+" />
            </Location>
            <OMIM>303630</OMIM>
            <Haploinsufficiency last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL4A5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
            <Triplosensitivity last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL4A5">No evidence available</Triplosensitivity>
          </Gene>
        </GeneList>
        <Name>NG_011977.2:g.(156309_156637)_(261456_?)del</Name>
        <VariantType>Deletion</VariantType>
        <HGVSlist>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_232" sequenceAccession="LRG_232">
              <Expression>LRG_232:g.(156309_156637)_(261456_?)del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_011977.2" sequenceAccession="NG_011977" sequenceVersion="2" change="g.(156309_156637)_(261456_?)del">
              <Expression>NG_011977.2:g.(156309_156637)_(261456_?)del</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </GermlineClassification>
          <SomaticClinicalImpact NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </SomaticClinicalImpact>
          <OncogenicityClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </OncogenicityClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="10460" DB="ClinVar" />
          <XRef ID="COL4A5_000378" DB="LOVD 3" />
          <XRef Type="Allelic variant" ID="303630.0003" DB="OMIM" />
        </XRefList>
        <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for the deletion haplotype of allelic variant 303630.0008 from the referenced entries in the COL4A5 database for the same citation.</Comment>
      </SimpleAllele>
      <SimpleAllele AlleleID="25499" VariationID="1810356">
        <GeneList>
          <Gene Symbol="COL4A5" FullName="collagen type IV alpha 5 chain" GeneID="1287" HGNC_ID="HGNC:2207" Source="submitted" RelationshipType="asserted, but not computed">
            <Location>
              <CytogeneticLocation>Xq22.3</CytogeneticLocation>
              <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="108439838" stop="108697545" display_start="108439838" display_stop="108697545" Strand="+" />
              <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="107683073" stop="107940774" display_start="107683073" display_stop="107940774" Strand="+" />
            </Location>
            <OMIM>303630</OMIM>
            <Haploinsufficiency last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL4A5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
            <Triplosensitivity last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL4A5">No evidence available</Triplosensitivity>
          </Gene>
        </GeneList>
        <Name>NG_011977.2:g.(5284_124140)_(145816_147960)del</Name>
        <VariantType>Deletion</VariantType>
        <Location>
          <CytogeneticLocation>Xq22.3</CytogeneticLocation>
        </Location>
        <HGVSlist>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="LRG_232" sequenceAccession="LRG_232">
              <Expression>LRG_232:g.(5284_124140)_(145816_147960)del</Expression>
            </NucleotideExpression>
          </HGVS>
          <HGVS Type="genomic">
            <NucleotideExpression sequenceAccessionVersion="NG_011977.2" sequenceAccession="NG_011977" sequenceVersion="2" change="g.(5284_124140)_(145816_147960)del">
              <Expression>NG_011977.2:g.(5284_124140)_(145816_147960)del</Expression>
            </NucleotideExpression>
          </HGVS>
        </HGVSlist>
        <Classifications>
          <GermlineClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </GermlineClassification>
          <SomaticClinicalImpact NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </SomaticClinicalImpact>
          <OncogenicityClassification NumberOfSubmissions="0" NumberOfSubmitters="0">
            <ReviewStatus>no classification for the single variant</ReviewStatus>
            <Description>no classification for the single variant</Description>
          </OncogenicityClassification>
        </Classifications>
        <XRefList>
          <XRef Type="Interpreted" ID="10460" DB="ClinVar" />
          <XRef ID="COL4A5_000000" DB="LOVD 3" />
          <XRef Type="Allelic variant" ID="303630.0008" DB="OMIM" />
        </XRefList>
        <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for the deletion haplotype of allelic variant 303630.0008 from the referenced entries in the COL4A5 database for the same citation.</Comment>
      </SimpleAllele>
      <Name>Multiple alleles</Name>
      <VariationType>Haplotype</VariationType>
      <OtherNameList>
        <Name>COL4A5, 3-PRIME AND PARTIAL 5-PRIME DELETION</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="303630.0008" DB="OMIM" />
      </XRefList>
    </Haplotype>
    <RCVList>
      <RCVAccession Title="Multiple alleles AND X-linked Alport syndrome" Accession="RCV000011206" Version="8">
        <ClassifiedConditionList TraitSetID="2968">
          <ClassifiedCondition DB="MedGen" ID="C4746986">X-linked Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-01-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-01-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-02-04" MostRecentSubmission="2019-02-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2968" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="220" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alport syndrome 1, X-linked recessive</ElementValue>
                <XRef ID="Alport+Syndrome/335" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked Alport syndrome</ElementValue>
                <XRef ID="MONDO:0010520" DB="MONDO" />
                <XRef ID="88917" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEPHROPATHY AND DEAFNESS, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="301050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">ATS</ElementValue>
                <XRef ID="GTR000525320" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="301050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLAS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ATS1</ElementValue>
                <XRef Type="MIM" ID="301050" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">COL4A5-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5785" />
                <XRef ID="5785" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16774" />
                <XRef ID="16774" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88917" DB="Orphanet" />
              <XRef ID="C4746986" DB="MedGen" />
              <XRef ID="MONDO:0010520" DB="MONDO" />
              <XRef Type="MIM" ID="301050" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31433" SubmissionDate="2019-01-31" DateLastUpdated="2019-02-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="303630.0008_ALPORT SYNDROME 1, X-LINKED" title="COL4A5, 3-PRIME AND PARTIAL 5-PRIME DELETION_ALPORT SYNDROME 1, X-LINKED" />
        <ClinVarAccession Accession="SCV000031433" DateUpdated="2019-02-04" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-31">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with severe Alport syndrome (ALS1; 301050) and end-stage renal disease (ESRD) by age 17, accompanied by deafness, Smeets et al. (1992) found deletion of exons encoding the noncollagenous domain and part of the collagenous region of the collagen IV alpha-5 chain. Transplantation with the kidney of an unrelated donor was followed by rapidly progressive anti-glomerular basement membrane nephritis, leading to loss of the transplant almost 7 months after grafting. His affected maternal grandfather died from renal failure at the age of 26 years. The deletion appeared to be present in heterozygous form in the mother and sister, both of whom displayed hematuria.</Attribute>
              <Citation>
                <CitationText>Smeets, H. J. M., Melenhorst, J. J., Lemmink, H. H., Schroder, C. H., Nelen, M. R., Zhou, J., Hostikka, S. L., Tryggvason, K., Ropers, H.-H., Jansweijer, M. C. E., Monnens, L. A. H., Brunner, H. G., van Oost, B. A. Different mutations in the COL4A5 collagen gene in two patients with different features of Alport syndrome. Kidney Int. 42: 83-88, 1992.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="301050" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A5" />
          </GeneList>
          <Name>COL4A5, 3-PRIME AND PARTIAL 5-PRIME DELETION</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-PRIME AND PARTIAL 5-PRIME DELETION</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="303630.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALPORT SYNDROME 1, X-LINKED</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="31433" TraitType="Disease" MappingType="Name" MappingValue="ALPORT SYNDROME 1, X-LINKED" MappingRef="Preferred">
        <MedGen CUI="C4746986" Name="X-linked Alport syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

